Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy combined with tegafur suppository in elderly esophageal cancer
ChiCTR2300073845Phase 2Recruiting
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tegafur in esophageal cancer (2 arms), sponsored by Second Affiliated Hospital of Xi'an Jiaotong University. Primary endpoints: Objective response rate (ORR) and Progression-free survival (PFS). Started May 2022; status: recruiting.
02
Drugs
tegafur
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on ChiCTR2300073845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073845.